Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials
Triall
Introduce
The crypto industry is showing excellent development results right now, and this is likely to continue. There is no doubt that cryptocurrencies have brought new opportunities to people and industries that are already generating excellent profits. But all this would not have happened had it not been for the participation in this system of cryptocurrency exchanges. It so happened that for the success of the entire crypto industry, auxiliary platforms are needed that make it possible to create value for cryptocurrencies and influence their price. At the moment, there are several types of crypto exchanges, namely centralized, decentralized and hybrid. Today I would like to tell you about the promising new crypto Triall and share information about its capabilities and benefits.
About Triall
Triall is a blockchain project with high relevance within the current COVID-19 pandemic. The team is building a digital ecosystem for clinical trials: a ± $200 billion market that focuses on evaluating the safety and efficacy of new medicines before these can enter the market. Triall is bringing ‘web 3.0’ thinking to medical research by applying blockchain and related decentralized technologies to streamline clinical trials. This should accelerate the introduction of new vaccines and therapeutics into society. Triall houses a professional team of medical research experts and Ph.D. scholars, all focused on bringing transparency, reliability, and operational excellence to the emerging digital clinical trials environment
The Triall project will release a range of blockchain-integrated clinical trial software applications, collaborating closely with medical researchers that are working in clinical trials on a daily basis. Each of these software applications targets specific, industry-validated pain points. The common objective of these software applications is to improve data integrity, auditability, and task efficiency in modern-day medical research processes. For more information and features about this revolutionary medical blockchain project, you may visit the Triall official website.
Core Solutions
Verial eTMFClinical document management application with blockchain proofs of data integrity and authenticity.
Triall CTMSLightweight trial management dashboard with blockchain API-driven data integration.
Atena PRMVendor selection and management platform with blockchain proofs of fair tender and bidding processes.
Token system
Triall’s two-token system
As part of growing their blockchain-enabled digital ecosystem for clinical trials, Triall will introduce a two-token system consisting of their main utility token TRL and its internal counterpart the Triall Application Credit (T-CRED). T-CRED gives the right to enter and use the services in the Triall ecosystem. It is the only token that can be used to pay for Triall solutions, can only be created by converting TRL, and is intended for use and adoption within the clinical research sector.
What is the utility of this two-token system?
Access to ecosystem utilities: TRL offers access to the applications and APIs offered within the Triall ecosystem, facilitated through the conversion of TRL to T-CRED.
Direct Peer-to-Peer (P2P) payment of stakeholders and clinical trial participants: Both TRL and T-CRED will function as a common currency in the ecosystem. They enable fast and secure payment of stakeholders who contribute to the ecosystem and enable automated milestone-based payments to the parties involved in a clinical trial consortium, such as clinical research sites or research subjects.
Community Engagement & Platform Maintenance: TRL is used to compensate and incentivize the community for contributions to the ecosystems. Some practical examples include:
- Clinical research quality management experts sharing best practices within our public knowledge base environment (Trialwiki);
- Academic Institutions and research centers sharing ‘big data’ for improved analytics and risk-based monitoring.
- Developers contributing to the infrastructure, such as bug bounty hunting or user experience testing;
- Community members building wallets, APIs, or promotional websites.
Governance of the Ecosystem: TRL functions to engage stakeholders in setting the course for the ecosystem (e.g. which apps to build, what community initiatives to support). Voting rights are based on individual TRL (or T-CRED) holdings and are increased through membership tiers.
Memberships & community rewards: Members who lock-up their tokens will receive unique benefits, such as premium features and additional voting rights. This mechanism approach will stimulate community growth and network effects. We have a unique system that differentiates between memberships for clinical research professionals and community rewards for token holders.
Partners
Conclusion
Triall provides an ingenious solution for the pharmaceutical industry and is the team behind TRL. It is decentralized software powered by people with the best knowledge and expertise in the fields of pharmaceuticals, data analytics, clinics, software developers, and blockchain experts. It will be very helpful, especially when it is difficult to find new drugs that can be used quickly amid the Covid-19 pandemic. Today, every pharmaceutical company will be able to save costs, accelerate clinical trials and distribution, and experience better drug quality and work more efficiently with Triall.
For more details, follow
Website: https://www.triall.io/
Twitter: https://twitter.com/triallofficial
Facebook: https://www.facebook.com/triallofficial/
Linkedin: https://linkedin.com/company/triallofficial
Telegram: https://t.me/triallcommunity
Author: bezzdavidandy
A sponsored article written for a bounty reward